Clinical importance of c-met protein expression in high grade astrocytic tumors

Neurologia Medico-Chirurgica

Volumn 38, Issue 12, 1998, Pages 851-859

  Hirose, Yuichi ^a,c   Kojima, Masaru ^a   Sagoh, Masachika ^a   Hayashi, Takuro ^a   Murakami, Hideki ^a   Shimazaki, Kenji ^b   Yoshida, Kazunari ^b   Kawase, Takeshi ^b  

^a ASHIKAGA RED CROSS HOSPITAL   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Astrocytic tumors; C Met; Epidermal growth factor receptor; MIB 1; Neuroepithelial tumors; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; SCATTER FACTOR RECEPTOR; STREPTAVIDIN BIOTIN PEROXIDASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC ANATOMY; NEUROEPITHELIOMA; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL;

EID: 0032418232     PISSN: 03872572     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.38.851     Document Type: Article

References (45)

1. Boccaccio C, Gaudino G, Gamarotta G, Comoglio PM: Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. J Biol Chem 269:12846-12851, 1994
2. Bottaro DP, Rubin JS, Faletto DL, Chan AML, Kmiecik TE, Vande Woude GF, Aaronson SA: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804, 1991
3. Brinkmann V, Foroutan H, Sachs M, Weidner KM, Birchmeier W: Hepatocyte growth factor induces a variety of tissue specific morphogenic programs in epithelial cells. J Cell Biol 131: 1573-1586, 1995
4. Burger PC, Sheithauer BW: Tumors of the Central Nervous System, ed 3. Washington, DC, AFIP, 1994, pp 205-221
5. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Guadino G, Tamagnone L, Coffer A, Marchisio PC, Comoglio PM: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641, 1992
6. Cox DR: Regression models and life tables. Journal of Royal Statistical Society (Series B) 34: 187-220, 1972
7. Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini PL, Cremona O, Campanacci M, Comoglio PM: The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 10: 739-749, 1995
8. Furukawa T, Duguid WP, Kobari M, Matsuno S, Tsao MS: Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. Am J Pathol 147: 889-895, 1995
9. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comoglio PM: Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 339: 155-156, 1989
10. Grant DS, Kleinmann HK, Goldberg ID, Bhargawa MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A 90: 1937-1941, 1993
11. Hirose Y, Kojima M, Sagoh M, Murakami H, Yoshida K, Shimazaki K, Kawase T: Immunohistochemical examination of c-met protein expression in astrocytic tumors. Acta Neuropathol (Berl) 95: 345-351, 1998
12. Hoshi M, Yoshida K, Shimazaki K, Sasaki H, Otani M, Kawase T: Correlation between MIB-1 staining indices and recurrence in low-grade astrocytomas. Brain Tumor Pathol 14: 47-51, 1997
13. Hsu DW, Louis DN, Efird JT, Hedley-Whyte ET: Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas. J Neuropathol Exp Neurol 56: 857-865, 1997
14. Joseph A, Weiss GH, Jin L, Fuchs A, Chowdhury S, O'Shaugnessy P, Goldberg ID, Rosen EM: Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst 87: 372-377, 1995
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. Journal of American Statistical Association 53: 457-481, 1958
16. Kleihues P, Burger PC, Sheithauer BW: Histological Typing of Tumors of the Central Nervous System, ed 2. Berlin, Springer-Verlag, 1993, pp 5-30
17. Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineberg E, Hudson EA, Resau JH, Vande Wonde GF: Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res 57: 5391-5398, 1997
18. Krasnoselsky A, Massay MJ, DeFrances MC, Michalopoulos G, Zarneger R, Ratner N: Hepatocyte growth factor is a mitogen for schwann cells and is present in neurofibromas. J Neurosci 14: 7284-7290, 1994
19. Leon SP, Folkerth RD, Black PM: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77: 362-372, 1996
20. Liu C, Park M, Tsao MS: Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. Oncogene 7: 181-185, 1992
21. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966
22. Matsumoto K, Hashimoto K, Yoshikawa K, Nakamura T: Marked stimulation of growth and motility of human keratinocyte by hepatocyte growth factor. Exp Cell Res 196: 114-120, 1991
23. Matsumoto K, Tajima H, Nakamura T: Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis. Biochem Biophys Res Commun 176: 45-51, 1991
24. McKeever PE, Ross DA, Strawderman MS, Brunberg JA, Greenberg HS, Junck L: A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters. J Neuropathol Exp Neurol 56: 798-805, 1997
25. Moghul A, Lin L, Beedle A, Kanbour-Shakir A, DeFrances MC, Liu Y, Zarnegar R: Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene 9: 2045-2052, 1994
26. Moriyama T, Kataoka H, Tsubouchi H, Koono M: Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro. FEBS Lett 372: 78-82, 1995
27. Nakamura M, Konishi N, Tsunoda S, Hiasa Y, Tsuzuki T, Inui T, Sakaki T: Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma. Cancer 80: 242-249, 1997
28. Nakamura T, Teramoto H, Ichihara A: Purification and characterization of a growth factor from rat platelets for mature mesenchymal hepatocytes in primary cultures. Proc Natl Acad Sci U S A 83: 6489-6493, 1986
29. Onda K, Davis RL, Shibuya M, Wilson C, Hoshino T: Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74: 1921-1926, 1994
30. Rahimi N, Saulnier R, Nakamura T, Park M, Elliott B: Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA Cell Biol 13: 1189-1197, 1994
31. Reifenberger J, Ring GU, Gies U, Cobbers JMJL, Oberstraß J, An HX, Niederacher D, Wechsler W, Reifenberger G: Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 55: 822-831, 1996
32. Rosen EM, Laterra J, Joseph A, Jin L, Fuchs A, Way DE, Witte M, Weinand M, Goldberg ID: Scatter factor expression and regulation in human glial tumors. Int J Cancer 67: 248-255, 1996
33. Singh-Kaw P, Zarnegar R, Siegfried JM: Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells. Am J Physiol 268: L1012-L1020, 1995
34. Stoker M, Gherardi E, Peryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 27: 239-242, 1987
35. Tahara E: Genetic alteration in human gastrointestinal cancers. Cancer 75: 1410-1417, 1995
36. Tajima H, Matsumoto K, Nakamura T: Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 202: 423-431, 1992
37. Tsao MS, Zhu H, Giaid A, Viallet J, Nakamura T, Park M: Hepatocyte growth factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ 4: 571-579, 1993
38. Tsarfaty I, Resau JH, Rulong S, Keyder I, Faletto DL, Vande Woude G: The c-met proto-oncogene receptor and lumen formation. Science 257: 1258-1261, 1992
39. U HS, Espiritu OD, Kelly PY, Klauber MR, Hatton JD: The role of the epidermal growth factor receptor in human gliomas: I. The control of cell growth. J Neurosurg 82: 841-846, 1995
40. U HS, Espiritu OD, Kelly PY, Klauber MR, Hatton JD: The role of the epidermal growth factor receptor in human gliomas: II. The control of glial process extension and the expression of glial fibrillary acidic protein. J Neurosurg 82: 847-857, 1995
41. Vila MR, Nakamura T, Real FX: Hepatocyte growth factor is a potent mitogen for normal human pancreas cells in vitro. Lab Invest 73: 409-418, 1995
42. Waha A, Baumann A, Wolf HK, Fimmers R, Neumann J, Kindermann D, Astrahantseff K, Blümcke I, von Deimling A, Schlegel U: Lack of prognostic relevance of alteration in the epidermal growth factor receptor-transforming growth factor - a pathway in human astrocytic gliomas. J Neurosurg 85: 634-641, 1996
43. Woolf AS, Kolatsi-Joannou M, Hardman P, Andermarcher E, Mooby C, Fine LG, Jat PS, Noble MD, Gherardi E: Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J Cell Biol 128: 171-184, 1995
44. Wullich B, Müller HW, Fischer U, Zang KD, Meese E: Amplified met gene linked to double minute in human glioblastoma. Eur J Cancer 29A: 1991-1995, 1993
45. Wullich B, Sattler HP, Fischer U, Meese E: Two dependent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. Anticancer Res 14: 577-580, 1994